Found: 15
Select item for more details and to access through your institution.
Scientific approaches toward improving cervical cancer elimination strategies.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 9, p. 1537, doi. 10.1002/ijc.34839
- By:
- Publication type:
- Article
Factors associated with parental intention to vaccinate their child against influenza, Finland, February to March, 2022: a web-based survey.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 49, p. 20, doi. 10.2807/1560-7917.ES.2023.28.49.2200828
- By:
- Publication type:
- Article
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7759, doi. 10.1002/cam4.4299
- By:
- Publication type:
- Article
Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.
- Published in:
- American Journal of Epidemiology, 2021, v. 190, n. 4, p. 506, doi. 10.1093/aje/kwaa121
- By:
- Publication type:
- Article
Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised HPV vaccination trial with moderate coverage.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 12, p. 3511, doi. 10.1002/ijc.33169
- By:
- Publication type:
- Article
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 3, p. 785, doi. 10.1002/ijc.32189
- By:
- Publication type:
- Article
Gender‐neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 9, p. 2299, doi. 10.1002/ijc.31618
- By:
- Publication type:
- Article
Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—<italic>Post‐hoc</italic> analysis of a community‐randomized clinical trial (II).
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 12, p. 2491, doi. 10.1002/ijc.31281
- By:
- Publication type:
- Article
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 5, p. 949, doi. 10.1002/ijc.31119
- By:
- Publication type:
- Article
Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 1, p. 204, doi. 10.1002/ijc.28646
- By:
- Publication type:
- Article
The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 6, p. 1459, doi. 10.1002/ijc.28145
- By:
- Publication type:
- Article
Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072088
- By:
- Publication type:
- Article